Search Results

HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens.

• Authors : Huhn, Gregory D.; Ramgopal, Moti; Jain, Mamta K.

• Source: PLoS ONE. January 29, 2020, Vol. 15 Issue 1, e0224875.

Record details

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.

• Authors : Hermansson, Linn; Yilmaz, Aylin; Price, Richard W.

• Source: PLoS ONE. December 11, 2019, Vol. 14 Issue 12, e0226276.

Record details

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors.

• Authors : Alejos, Belén; Suárez-García, Inés; Bisbal, Otilia

• Source: PLoS ONE. August 26, 2019, Vol. 14 Issue 8, e0221598.

Record details

Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study.

• Authors : Elmekaty EZI; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.; Alibrahim R

Subjects: HIV Infections* ; COVID-19 Drug Treatment*; Adult

• Source: PloS one [PLoS One] 2022 May 04; Vol. 17 (5), pp. e0267884. Date of Electronic Publication: 2022 May 04 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details